Related Experiment Video
Updated: Aug 30, 2026

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling
Published on: October 14, 2021
Aberrant expression of T-plastin in Sezary cells
Ming-wan Su1, Irene Dorocicz, Wieslawa H Dragowska
1Chieng Genomics Centre, Laboratory of Predictive Medicine and Therapeutics, Vancouver Coastal Health Research Institute, Vancouver, British Columbia, V5Z 4E8 Canada.
Abstract:
Mycosis fungoides (MF) and its leukemic variant, Sezary syndrome (SS), are the most common cutaneous T-cell lymphomas, with a combined incidence of 0.36 of 100,000 person-years. Although thought to be closely related to mature T-helper cells, the true nature of the cancer cells in MF/SS is unknown. In addition, there is no known specific marker for MF/SS cancer cells, which can result in difficulties in the diagnosis and treatment. To identify MF/SS-specific markers, Sezary cancer cells were analyzed with a global genomic screening tool, the modified representational difference analysis. It was discovered that unlike T-helper cells from healthy individuals or patients with nonmalignant dermatoses, Sezary cells from most patients with Sezary syndrome aberrantly expressed T-plastin mRNA and protein. This is the first time T-plastin protein, a cytoplasmic protein regulating actin assembly and cellular motility, has been detected in the hematopoietic cells. Therefore, T-plastin has the potential to be a Sezary cell-specific marker valuable for diagnostic and treatment of Sezary syndrome.
Insights
Researchers identified T-plastin as a potential specific marker for Sezary syndrome (SS), a rare cancer. This discovery could improve diagnosis and treatment for this cutaneous T-cell lymphoma.
Area of Science:
- Hematology
- Oncology
- Dermatology
Background:
- Mycosis fungoides (MF) and Sezary syndrome (SS) are the most common cutaneous T-cell lymphomas.
- The exact nature and specific markers for MF/SS cancer cells remain unknown, complicating diagnosis and treatment.
- Current understanding suggests a relation to mature T-helper cells, but definitive proof is lacking.
Purpose of the Study:
- To identify specific molecular markers for Sezary cells in Sezary syndrome.
- To investigate potential diagnostic and therapeutic targets for MF/SS.
Main Methods:
- Global genomic screening using modified representational difference analysis on Sezary cells.
- Analysis of T-plastin mRNA and protein expression in Sezary cells compared to healthy controls and patients with nonmalignant dermatoses.
Main Results:
- Sezary cells from most Sezary syndrome patients aberrantly expressed T-plastin mRNA and protein.
- T-plastin, a regulator of actin assembly and cellular motility, was detected in hematopoietic cells for the first time.
- This aberrant expression was not observed in T-helper cells from healthy individuals or patients with nonmalignant dermatoses.
Conclusions:
- T-plastin shows potential as a Sezary cell-specific marker.
- This finding could significantly aid in the diagnosis and treatment of Sezary syndrome.
- Further research into T-plastin's role may open new therapeutic avenues for cutaneous T-cell lymphomas.
Related Concept Videos
Abnormal Proliferation
Cytoskeletal Linker Proteins - Plakins

